Phase 3 trial shows overall survival benefit from adjuvant therapy in kidney cancer patients

  • Post author:
  • Post category:uncategorized

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.